UTSA researchers receive boost with technology from German biosciences company
(June 12, 2015) – The Center for Innovative Drug Discovery (CIDD), a joint venture between UTSA and the University of Texas Health Science Center at San Antonio (UTHSCSA), has entered into a research development partnership with German-based company Cytocentrics Biosciences.
The partnership has significant potential impact for drug discovery research across multiple therapeutic disciplines, and will benefit several departments at both institutions. It also complements UTSA’s drive to Tier One status by creating opportunities for excellence in education and research.
The CIDD launched in 2012 with $3.5 million in funding and provides expertise and core services to spur the development of pre-clinical drug candidates. In Fall 2014, center researchers Stanton McHardy and Rong Li received $1.9 million from the Cancer Prevention & Research Institute of Texas to develop next-generation breast cancer treatment drugs.
The unique research center is composed of a 2,000 square-foot, state-of-the-art Medicinal Chemistry and Synthesis Core Facility on the UTSA West Campus. The technological center provides chemistry and synthesis services to support small molecule drug discovery efforts. The center also includes a High-Throughput Screening Facility at the UT Health Science Center.
Cytocentrics has agreed to donate two Cytopatch machines to the CIDD that will enable researchers to advance novel therapies in the areas of biochemistry, physiology and neuroscience. Cytocentrics manufactures the CytoPatch machine, which automates a medical “patch clamp” technique that looks at cell membranes to determine how they will react to different drugs.
Over the long term, the donation will help CIDD researchers train students and could make them more competitive for extramural funding.
This week, Cytocentrics announced it was relocating its corporate headquarters and operatons to San Antonio after City Council members approved a one million grant over five years. As part of the city's agreement with the company, Cytocentrics will invest $15 million and create 300 high-wage jobs with an average salary of $70,000.
“San Antonio is known for its collaborative spirit. Cytocentrics’ relocation to San Antonio serves as an example of how the private sector, academia and the City can partner together to enable progress, drive innovation and ultimately create more jobs,” said Mauli Agrawal, UTSA Vice President for Research.
Learn more about the Center for Innovative Drug Discovery.
Connect online with UTSA on Twitter, Facebook, YouTube and Instagram.
Events
At this memorable celebration, UTSA graduates will be introduced one-by-one to cross the stage and accept their doctoral degrees.
Arts Building Recital Hall, Main CampusRoadrunner Walk is an event for graduating students to have a memorable walk on campus to celebrate an important milestone and their achievements. Graduates will walk along the Paseo while being celebrated by the UTSA community, friends, and family members.
Student Union Paseo, Main CampusJoin us for a tribute to Willie Velásquez, honoring the legacy of Willie Velásquez, a pivotal figure in shaping the history of Latino and Hispanic participation in the American voting process. Delve into his life and contributions as a champion of Latino voting rights. Moderated by UTSA's Teresa Niño, the event will feature influential voices, including Jane Velásquez, María Antonietta Berriozábal, Dora Oliva, and Anthony Gonzales.
Buena Vista Building, Buena Vista Theater, Downtown CampusCelebrate the accomplishments of College of Education and Human Development, College for Health, Community and Policy, College of Sciences and University College.
Alamodome, 100 Montana St.Celebrate the accomplishments of Alvarez College of Business, College of Liberal and Fine Arts and Klesse College of Engineering and Integrated Design.
Alamodome, 100 Montana St.